Management of Post Menopausal Syndrome with unani medicine.

Efficacy of Tukhme Sambhalu (Vitex negundo) in Post Menopausal Syndrome (Multazima-Baad-Az-Inqtaetams).A Randomised Placebo controlled study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054296

Enrollment

Registered

2023-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs Health Condition 2: R688- Other general symptoms and signs Health Condition 3: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: Tukhm-e-sambhalu ( Vitex negundo): Parts used - seeds Dose - powder 5gms Twice a day with sharbat anar 10 ml Duration - 3 months Control Intervention1: Placebo: Roasted wheat flour Do

Eligibility

Inclusion criteria

Inclusion criteria: Women experiencing symptoms accompanying natural menopause ( during perimenopause or postmenopausal periods) or surgical menopause. Women with diabetes and hypertension have been included. Clinically stable patient.

Exclusion criteria

Exclusion criteria: Women with any kind of malignancies. Women with undiagnosed vaginal bleeding. Patient with deranged kidney, hepatic and Cardiac profiles. Daignosed patients of psychiatric disorders.

Design outcomes

Primary

Measure	Time frame
Any effect like cure, improved, relieved or worsenTimepoint: 3 months	—

Secondary

Measure	Time frame
Any effect on quality of lifeTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Shehzadi Sultana

Government nizamia tibbi college and hospital charminar

drssntc@gmail.com9908624090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026